Hereditary spastic paraplegia type 11: Clinicogenetic lessons from 339 patients

•There is no mutational hot spot in the KIAA1840 gene.•The mutational spectrum of SPG11 is wide, and frameshift mutations are the most common type followed by nonsense mutations.•SPG11 exhibited significant clinical and genetic heterogeneity.•No clear genotype-phenotype correlation was observed. Her...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of clinical neuroscience 2021-03, Vol.85, p.67-71
1. Verfasser: Du, Juan
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 71
container_issue
container_start_page 67
container_title Journal of clinical neuroscience
container_volume 85
creator Du, Juan
description •There is no mutational hot spot in the KIAA1840 gene.•The mutational spectrum of SPG11 is wide, and frameshift mutations are the most common type followed by nonsense mutations.•SPG11 exhibited significant clinical and genetic heterogeneity.•No clear genotype-phenotype correlation was observed. Hereditary spastic paraplegia type 11 (SPG11) is the most common subtype of autosomal recessive hereditary spastic paraplegia (HSP), to date, there are more than 181 different KIAA1840 gene mutations detected, and yet the genetic landscape of SPG11 is far from complete. To find the clinical and genetic characteristics of SPG11, we performed a reanalysis of the clinical features and genotype-phenotype correlations in all reported studies exhibiting SPG11 mutations. A total of 339 patients were collected, their mean age at onset was 13.10 ± 3.65 years, with initial symptoms like gait disturbance (107/195, 54.87%) and mental retardation (47/195, 24.10%). Cognitive decline (228/270, 84.44%) was the most common complex manifestation stepped by dysarthria (134/195, 68.72%), neuropathy (112/177, 63.28%), amyatrophy, sphincter disturbance (60/130, 46.15%) and ataxia (90/194, 46.39%). The most common brain MRI abnormality is thinning of the corpus callosum (TCC) (173/190, 91.05%), followed by periventricular white matter changes (130/158, 82.28%), cerebral or cerebellar cortical atrophy (55/107, 51.40%). The mutational spectrum associated with KIAA1840 gene is wide, and frameshift mutations are the most common type followed by nonsense mutations. Our reanalysis demonstrated that SPG11 exhibited significant clinical and genetic heterogeneity, and no clear genotype-phenotype correlation was observed. There is no mutational hot spot in the KIAA1840 gene, which emphasizes the need to analyse the whole gene in clinical practice. In addition to conventional genetic testing methods, further mRNA analysis should be conducted on some cases to yield a definitive diagnosis.
doi_str_mv 10.1016/j.jocn.2020.11.036
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2489605793</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0967586820316593</els_id><sourcerecordid>2489605793</sourcerecordid><originalsourceid>FETCH-LOGICAL-c422t-3a1821cf112fb746af8c70b052de5f369b7f53c3eaa9fbe193d71f6b26eb90b3</originalsourceid><addsrcrecordid>eNp9kEFLwzAYhoMobk7_gAfp0UtnvqRNG_EiQ50w2GX3kKZfRkrX1qQT9u_N2PTo6YOP533hfQi5BzoHCuKpmTe96eaMsviAOeXigkwh5yxlIueXZEqlKNK8FOWE3ITQUEplxuk1mXCel1BIPiXrJXqs3aj9IQmDDqMzyaC9HlrcOp2MhwETgOdk0brOmX6LHR6RFkPou5BY3-8SzmXMjA67MdySK6vbgHfnOyOb97fNYpmu1h-fi9dVajLGxpRrKBkYC8BsVWRC29IUtKI5qzG3XMiqsDk3HLWWtkKQvC7AiooJrCSt-Iw8nmoH33_tMYxq54LBttUd9vugWFZKQfM4MaLshBrfh-DRqsG7XdyrgKqjR9Woo0d19KgAVPQYQw_n_n21w_ov8isuAi8nAOPIb4deBRMFmOjSoxlV3bv_-n8APfmEEQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2489605793</pqid></control><display><type>article</type><title>Hereditary spastic paraplegia type 11: Clinicogenetic lessons from 339 patients</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Du, Juan</creator><creatorcontrib>Du, Juan</creatorcontrib><description>•There is no mutational hot spot in the KIAA1840 gene.•The mutational spectrum of SPG11 is wide, and frameshift mutations are the most common type followed by nonsense mutations.•SPG11 exhibited significant clinical and genetic heterogeneity.•No clear genotype-phenotype correlation was observed. Hereditary spastic paraplegia type 11 (SPG11) is the most common subtype of autosomal recessive hereditary spastic paraplegia (HSP), to date, there are more than 181 different KIAA1840 gene mutations detected, and yet the genetic landscape of SPG11 is far from complete. To find the clinical and genetic characteristics of SPG11, we performed a reanalysis of the clinical features and genotype-phenotype correlations in all reported studies exhibiting SPG11 mutations. A total of 339 patients were collected, their mean age at onset was 13.10 ± 3.65 years, with initial symptoms like gait disturbance (107/195, 54.87%) and mental retardation (47/195, 24.10%). Cognitive decline (228/270, 84.44%) was the most common complex manifestation stepped by dysarthria (134/195, 68.72%), neuropathy (112/177, 63.28%), amyatrophy, sphincter disturbance (60/130, 46.15%) and ataxia (90/194, 46.39%). The most common brain MRI abnormality is thinning of the corpus callosum (TCC) (173/190, 91.05%), followed by periventricular white matter changes (130/158, 82.28%), cerebral or cerebellar cortical atrophy (55/107, 51.40%). The mutational spectrum associated with KIAA1840 gene is wide, and frameshift mutations are the most common type followed by nonsense mutations. Our reanalysis demonstrated that SPG11 exhibited significant clinical and genetic heterogeneity, and no clear genotype-phenotype correlation was observed. There is no mutational hot spot in the KIAA1840 gene, which emphasizes the need to analyse the whole gene in clinical practice. In addition to conventional genetic testing methods, further mRNA analysis should be conducted on some cases to yield a definitive diagnosis.</description><identifier>ISSN: 0967-5868</identifier><identifier>EISSN: 1532-2653</identifier><identifier>DOI: 10.1016/j.jocn.2020.11.036</identifier><identifier>PMID: 33581793</identifier><language>eng</language><publisher>Scotland: Elsevier Ltd</publisher><subject>Adolescent ; Age of Onset ; Brain MRI ; Child ; Female ; Genetic Association Studies ; Genotype-phenotype correlation ; Hereditary spastic paraplegia ; Humans ; KIAA1840 ; Male ; Mutation ; Proteins - genetics ; Spastic Paraplegia, Hereditary - complications ; Spastic Paraplegia, Hereditary - genetics ; Spastic Paraplegia, Hereditary - pathology ; SPG11</subject><ispartof>Journal of clinical neuroscience, 2021-03, Vol.85, p.67-71</ispartof><rights>2020 Elsevier Ltd</rights><rights>Copyright © 2020 Elsevier Ltd. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c422t-3a1821cf112fb746af8c70b052de5f369b7f53c3eaa9fbe193d71f6b26eb90b3</citedby><cites>FETCH-LOGICAL-c422t-3a1821cf112fb746af8c70b052de5f369b7f53c3eaa9fbe193d71f6b26eb90b3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.jocn.2020.11.036$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,777,781,3537,27905,27906,45976</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33581793$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Du, Juan</creatorcontrib><title>Hereditary spastic paraplegia type 11: Clinicogenetic lessons from 339 patients</title><title>Journal of clinical neuroscience</title><addtitle>J Clin Neurosci</addtitle><description>•There is no mutational hot spot in the KIAA1840 gene.•The mutational spectrum of SPG11 is wide, and frameshift mutations are the most common type followed by nonsense mutations.•SPG11 exhibited significant clinical and genetic heterogeneity.•No clear genotype-phenotype correlation was observed. Hereditary spastic paraplegia type 11 (SPG11) is the most common subtype of autosomal recessive hereditary spastic paraplegia (HSP), to date, there are more than 181 different KIAA1840 gene mutations detected, and yet the genetic landscape of SPG11 is far from complete. To find the clinical and genetic characteristics of SPG11, we performed a reanalysis of the clinical features and genotype-phenotype correlations in all reported studies exhibiting SPG11 mutations. A total of 339 patients were collected, their mean age at onset was 13.10 ± 3.65 years, with initial symptoms like gait disturbance (107/195, 54.87%) and mental retardation (47/195, 24.10%). Cognitive decline (228/270, 84.44%) was the most common complex manifestation stepped by dysarthria (134/195, 68.72%), neuropathy (112/177, 63.28%), amyatrophy, sphincter disturbance (60/130, 46.15%) and ataxia (90/194, 46.39%). The most common brain MRI abnormality is thinning of the corpus callosum (TCC) (173/190, 91.05%), followed by periventricular white matter changes (130/158, 82.28%), cerebral or cerebellar cortical atrophy (55/107, 51.40%). The mutational spectrum associated with KIAA1840 gene is wide, and frameshift mutations are the most common type followed by nonsense mutations. Our reanalysis demonstrated that SPG11 exhibited significant clinical and genetic heterogeneity, and no clear genotype-phenotype correlation was observed. There is no mutational hot spot in the KIAA1840 gene, which emphasizes the need to analyse the whole gene in clinical practice. In addition to conventional genetic testing methods, further mRNA analysis should be conducted on some cases to yield a definitive diagnosis.</description><subject>Adolescent</subject><subject>Age of Onset</subject><subject>Brain MRI</subject><subject>Child</subject><subject>Female</subject><subject>Genetic Association Studies</subject><subject>Genotype-phenotype correlation</subject><subject>Hereditary spastic paraplegia</subject><subject>Humans</subject><subject>KIAA1840</subject><subject>Male</subject><subject>Mutation</subject><subject>Proteins - genetics</subject><subject>Spastic Paraplegia, Hereditary - complications</subject><subject>Spastic Paraplegia, Hereditary - genetics</subject><subject>Spastic Paraplegia, Hereditary - pathology</subject><subject>SPG11</subject><issn>0967-5868</issn><issn>1532-2653</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kEFLwzAYhoMobk7_gAfp0UtnvqRNG_EiQ50w2GX3kKZfRkrX1qQT9u_N2PTo6YOP533hfQi5BzoHCuKpmTe96eaMsviAOeXigkwh5yxlIueXZEqlKNK8FOWE3ITQUEplxuk1mXCel1BIPiXrJXqs3aj9IQmDDqMzyaC9HlrcOp2MhwETgOdk0brOmX6LHR6RFkPou5BY3-8SzmXMjA67MdySK6vbgHfnOyOb97fNYpmu1h-fi9dVajLGxpRrKBkYC8BsVWRC29IUtKI5qzG3XMiqsDk3HLWWtkKQvC7AiooJrCSt-Iw8nmoH33_tMYxq54LBttUd9vugWFZKQfM4MaLshBrfh-DRqsG7XdyrgKqjR9Woo0d19KgAVPQYQw_n_n21w_ov8isuAi8nAOPIb4deBRMFmOjSoxlV3bv_-n8APfmEEQ</recordid><startdate>202103</startdate><enddate>202103</enddate><creator>Du, Juan</creator><general>Elsevier Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>202103</creationdate><title>Hereditary spastic paraplegia type 11: Clinicogenetic lessons from 339 patients</title><author>Du, Juan</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c422t-3a1821cf112fb746af8c70b052de5f369b7f53c3eaa9fbe193d71f6b26eb90b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Adolescent</topic><topic>Age of Onset</topic><topic>Brain MRI</topic><topic>Child</topic><topic>Female</topic><topic>Genetic Association Studies</topic><topic>Genotype-phenotype correlation</topic><topic>Hereditary spastic paraplegia</topic><topic>Humans</topic><topic>KIAA1840</topic><topic>Male</topic><topic>Mutation</topic><topic>Proteins - genetics</topic><topic>Spastic Paraplegia, Hereditary - complications</topic><topic>Spastic Paraplegia, Hereditary - genetics</topic><topic>Spastic Paraplegia, Hereditary - pathology</topic><topic>SPG11</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Du, Juan</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of clinical neuroscience</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Du, Juan</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Hereditary spastic paraplegia type 11: Clinicogenetic lessons from 339 patients</atitle><jtitle>Journal of clinical neuroscience</jtitle><addtitle>J Clin Neurosci</addtitle><date>2021-03</date><risdate>2021</risdate><volume>85</volume><spage>67</spage><epage>71</epage><pages>67-71</pages><issn>0967-5868</issn><eissn>1532-2653</eissn><abstract>•There is no mutational hot spot in the KIAA1840 gene.•The mutational spectrum of SPG11 is wide, and frameshift mutations are the most common type followed by nonsense mutations.•SPG11 exhibited significant clinical and genetic heterogeneity.•No clear genotype-phenotype correlation was observed. Hereditary spastic paraplegia type 11 (SPG11) is the most common subtype of autosomal recessive hereditary spastic paraplegia (HSP), to date, there are more than 181 different KIAA1840 gene mutations detected, and yet the genetic landscape of SPG11 is far from complete. To find the clinical and genetic characteristics of SPG11, we performed a reanalysis of the clinical features and genotype-phenotype correlations in all reported studies exhibiting SPG11 mutations. A total of 339 patients were collected, their mean age at onset was 13.10 ± 3.65 years, with initial symptoms like gait disturbance (107/195, 54.87%) and mental retardation (47/195, 24.10%). Cognitive decline (228/270, 84.44%) was the most common complex manifestation stepped by dysarthria (134/195, 68.72%), neuropathy (112/177, 63.28%), amyatrophy, sphincter disturbance (60/130, 46.15%) and ataxia (90/194, 46.39%). The most common brain MRI abnormality is thinning of the corpus callosum (TCC) (173/190, 91.05%), followed by periventricular white matter changes (130/158, 82.28%), cerebral or cerebellar cortical atrophy (55/107, 51.40%). The mutational spectrum associated with KIAA1840 gene is wide, and frameshift mutations are the most common type followed by nonsense mutations. Our reanalysis demonstrated that SPG11 exhibited significant clinical and genetic heterogeneity, and no clear genotype-phenotype correlation was observed. There is no mutational hot spot in the KIAA1840 gene, which emphasizes the need to analyse the whole gene in clinical practice. In addition to conventional genetic testing methods, further mRNA analysis should be conducted on some cases to yield a definitive diagnosis.</abstract><cop>Scotland</cop><pub>Elsevier Ltd</pub><pmid>33581793</pmid><doi>10.1016/j.jocn.2020.11.036</doi><tpages>5</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0967-5868
ispartof Journal of clinical neuroscience, 2021-03, Vol.85, p.67-71
issn 0967-5868
1532-2653
language eng
recordid cdi_proquest_miscellaneous_2489605793
source MEDLINE; Elsevier ScienceDirect Journals
subjects Adolescent
Age of Onset
Brain MRI
Child
Female
Genetic Association Studies
Genotype-phenotype correlation
Hereditary spastic paraplegia
Humans
KIAA1840
Male
Mutation
Proteins - genetics
Spastic Paraplegia, Hereditary - complications
Spastic Paraplegia, Hereditary - genetics
Spastic Paraplegia, Hereditary - pathology
SPG11
title Hereditary spastic paraplegia type 11: Clinicogenetic lessons from 339 patients
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-17T12%3A07%3A11IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Hereditary%20spastic%20paraplegia%20type%2011:%20Clinicogenetic%20lessons%20from%20339%20patients&rft.jtitle=Journal%20of%20clinical%20neuroscience&rft.au=Du,%20Juan&rft.date=2021-03&rft.volume=85&rft.spage=67&rft.epage=71&rft.pages=67-71&rft.issn=0967-5868&rft.eissn=1532-2653&rft_id=info:doi/10.1016/j.jocn.2020.11.036&rft_dat=%3Cproquest_cross%3E2489605793%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2489605793&rft_id=info:pmid/33581793&rft_els_id=S0967586820316593&rfr_iscdi=true